Brahmana Askandar Tjokroprawiro

ORCID: 0000-0003-1658-3477 · 4 papers in corpus
observational 2025
Comparison of PD-L1, CTR-1, VEGF, and p53 expression in sensitive and resistant epithelial ovarian cancer (EOC) patients to platinum-based chemotherapy
Narra J ·doi:10.52225/narra.v5i1.1419

The current standard treatment for ovarian cancer is a combination of cytoreductive surgery and platinum-based chemotherapy; however, many patients develop resistance, leading to a high recurrence rate. The aim of this study was to analyze …

observational 2024
Clinicopathological analysis of giant ovarian tumors
European journal of obstetrics & gynecology and reproductive biology: X ·doi:10.1016/j.eurox.2024.100318

OBJECTIVE: This study aims to analyze giant ovarian tumors' clinical and pathological characteristics. MATERIAL AND METHODS: This was an analytical observational study. Medical records of all patients with giant ovarian tumors who underwen…

2024
Huge endometrioma mimicking ovarian malignancy: report of three cases, what radiology should considered?
·doi:10.3802/jgo.2024.35.s2.p38
case-report 2023
Advanced Stage Clear Cell Ovarian Carcinoma Mimicking Uterine Sarcoma Without Gross Residual Tumor During Primary Surgery: A Case Report
Clinical medicine insights. Case reports ·doi:10.1177/11795476231166623

BACKGROUND: Clear cell ovarian carcinoma is rare and accounts for 1%-12% of ovarian epithelial carcinomas, depending on ethnicity. The prevalence of clear cell ovarian carcinoma in Asian, White, and Black women is 11.1%%, 4.8%, and 3.1%, re…